Therapeutic L-asparaginase: upstream, downstream and beyond (2017)
Source: Critical Reviews in Biotechnology. Unidade: FCF
Subjects: ENZIMAS, NEOPLASIAS, BIOTECNOLOGIA
ABNT
LOPES, André Moreni et al. Therapeutic L-asparaginase: upstream, downstream and beyond. Critical Reviews in Biotechnology, v. 37, n. 1, p. 82-99, 2017Tradução . . Disponível em: https://doi.org/10.3109/07388551.2015.1120705. Acesso em: 21 ago. 2024.APA
Lopes, A. M., Nascimento, L. de O., Ribeiro, A., Tairum Junior, C. A., Breyer, C. A., Oliveira, M. A. de, et al. (2017). Therapeutic L-asparaginase: upstream, downstream and beyond. Critical Reviews in Biotechnology, 37( 1), 82-99. doi:10.3109/07388551.2015.1120705NLM
Lopes AM, Nascimento L de O, Ribeiro A, Tairum Junior CA, Breyer CA, Oliveira MA de, Monteiro G, Motta CMS, Magalhães P de O, Avendaño JGF, Cavaco Paulo AM, Mazzola PG, Rangel-Yagui C de O, Sette LD, Converti A, Pessoa Junior A. Therapeutic L-asparaginase: upstream, downstream and beyond [Internet]. Critical Reviews in Biotechnology. 2017 ; 37( 1): 82-99.[citado 2024 ago. 21 ] Available from: https://doi.org/10.3109/07388551.2015.1120705Vancouver
Lopes AM, Nascimento L de O, Ribeiro A, Tairum Junior CA, Breyer CA, Oliveira MA de, Monteiro G, Motta CMS, Magalhães P de O, Avendaño JGF, Cavaco Paulo AM, Mazzola PG, Rangel-Yagui C de O, Sette LD, Converti A, Pessoa Junior A. Therapeutic L-asparaginase: upstream, downstream and beyond [Internet]. Critical Reviews in Biotechnology. 2017 ; 37( 1): 82-99.[citado 2024 ago. 21 ] Available from: https://doi.org/10.3109/07388551.2015.1120705